Skip to main content
An official website of the United States government

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

  • All Headings will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Name, Email, Phone Room Group(s)/Office
Evans Williams, Felicia, M.B.A.
felicia.evanslong@nih.gov
240-276-5076
5E636 Program Analyst | Cancer Biomarkers
Fu, Sidney, M.D.
sidney.fu@nih.gov
240-276-6669
5E134 Program Officer | Cancer Biomarkers
Hodges, Nick, Ph.D.
nick.hodges@nih.gov
240-276-7844
5E616 Program Officer | Cancer Biomarkers
Kohaar, Indu, Ph.D., M.Phil., M.Sc.
indu.kohaar@nih.gov
240-620-0875
5E612 Program Officer | Cancer Biomarkers
Marquez, Guillermo, Ph.D.
guillermo.marquez@nih.gov
240-276-7035
5E132 Program Officer | Cancer Biomarkers
Mazurchuk, Richard, Ph.D.
richard.mazurchuk@nih.gov
240-276-7126
5E582 Program Officer | Cancer Biomarkers
Orr, Susan
susan.orr@nih.gov
240-276-5001
5E626 Program Support Assistant | Cancer Biomarkers
Patriotis, Christos, Ph.D., M.Sc.
christos.patriotis@nih.gov
240-276-7134
5E614 Program Officer | Cancer Biomarkers
Petruzzelli, Angie
angie.petruzzelli@nih.gov
240-276-5076
5E624 Program Support Assistant | Cancer Biomarkers
Srivastava, Sudhir, Ph.D., M.P.H.
sudhir.srivastava@nih.gov
240-276-7028
5E136 Chief | Cancer Biomarkers
Wang, Wendy, Ph.D., M.Sc.
wendy.wang@nih.gov
240-276-7117
5E566 Program Officer | Cancer Biomarkers
Young, Matthew, Ph.D.
matthew.young@nih.gov
240-276-5846
5E610 Program Officer | Cancer Biomarkers

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Pandharipande, Pari Vijay

Ohio State University
United States

Precision Management of Cystic Precursors to Pancreatic Cancer 5R01CA237133-06 Matthew Young, Ph.D.
Papadopoulos, Nickolas

Johns Hopkins University
United States

Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids 5U01CA230691-07
Patel, Abhijit

Yale University
United States

Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood 5U01CA233364-05 Nick Hodges, Ph.D.
Paulson, Thomas G

Fred Hutchinson Cancer Center
United States

The microbiome ecosystem of Barrett's esophagus and progression to cancer 5R21CA259687-02 Matthew Young, Ph.D.
Permuth, Jennifer B.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology 4R37CA229810-06 Matthew Young, Ph.D.
Pitteri, Sharon

Stanford University
United States

Glycosylation and Immune Evasion in Urologic Tumors 5U01CA226051-05 Richard Mazurchuk, Ph.D.
Pollack, Alan

University Of Miami School Of Medicine
United States

MRI Imaging and Biomarkers for Early Detection of Aggressive Prostate Cancer 5U01CA239141-05 Richard Mazurchuk, Ph.D.
Pozdeyev, Nikita

University Of Colorado Denver
United States

Genetic architecture of thyroid cancer and its clinical utility 1R21CA282380-01A1 Wendy Wang, Ph.D., M.Sc.
Punnen, Sanoj

University Of Miami School Of Medicine
United States

The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection 5R01CA272766-02 Matthew Young, Ph.D.
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-11
Rosser, Charles J

Cedars-Sinai Medical Center
United States

A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology 5R01CA277810-03 Guillermo Marquez, Ph.D.
Rotemberg, Veronica Miriam

Sloan-Kettering Inst Can Research
United States

M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection 5U24CA264369-03 Guillermo Marquez, Ph.D.
Saenger, Yvonne Margaret

Albert Einstein College Of Medicine
United States

Applying pathomics to establish a biosignature for aggressive skin melanoma 5R01CA260375-04 Guillermo Marquez, Ph.D.
Salami, Simpa Samuel

University Of Michigan At Ann Arbor
United States

Defining the Biological Arc of Grade Group 1 Prostate Cancer 5R37CA283857-02 Guillermo Marquez, Ph.D.
Salkowski, Lonie

University Of Wisconsin-Madison
United States

Defining and Optimizing Critical Interpretation Skills in Screening Mammography to Improve Cancer Detection 5R37CA262110-04 Guillermo Marquez, Ph.D.